The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Sylvester, R. J., van der Meijden, A. P. M., Oosterlinck, W., Witjes, J. A., Bouffioux, C., Denis, L., Newling, D. W. W., & Kurth, K. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.031 · Cited by 3,013
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
Receptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Choi, W., Porten, S., Kim, S., Willis, D., Plimack, E. R., Hoffman-Censits, J., Roth, B., Cheng, T., Tran, M., Lee, I.-L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.009 · Cited by 1,716
Hoadley, K. A., Yau, C., Wolf, D. M., Cherniack, A. D., Tamborero, D., Ng, S., Leiserson, M. D. M., Niu, B., McLellan, M. D., Uzunangelov, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.049 · Cited by 1,499
World Health Organization Classification of Tumours
Jn, E. (2004) · Medical Entomology and Zoology · Cited by 1,473
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Roberts, S. A., Lawrence, M. S., Klimczak, L. J., Grimm, S. A., Fargo, D., Stojanov, P., Kiezun, A., Kryukov, G. V., Carter, S. L., Saksena, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2702 · Cited by 1,167
Receptor Specificity of the Fibroblast Growth Factor Family
Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., & Ornitz, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601252200 · Cited by 1,164
A Molecular Taxonomy for Urothelial Carcinoma
Sjödahl, G., Lauss, M., Lövgren, K., Chebil, G., Gudjonsson, S., Veerla, S., Patschan, O., Aine, M., Fernö, M., Ringnér, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0077-t · Cited by 944
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Damrauer, J. S., Hoadley, K. A., Chism, D. D., Fan, C., Tiganelli, C. J., Wobker, S. E., Yeh, J. J., Milowsky, M. I., Iyer, G., Parker, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318376111 · Cited by 877
Histological Typing of Urinary Bladder Tumours
Mostofi, F. K., Davis, C. J., Sesterhenn, I. A., & Sobin, L. H. (1999) · Springer eBooks · doi:10.1007/978-3-642-59871-5 · Cited by 758
Evidence for APOBEC3B mutagenesis in multiple human cancers
Burns, M. B., Temiz, N. A., & Harris, R. S. (2013) · Nature Genetics · doi:10.1038/ng.2701 · Cited by 755
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., & Radvanyi, F. (1999) · Nature Genetics · doi:10.1038/12615 · Cited by 713
Chan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti, J., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 660
Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck, C., Ohneseit, P. F., Gonzalez‐Zulueta, M., Esrig, D., Miyao, N., Tsai, Y., Lerner, S. P., Schmütte, C., Yang, A. S., & Cote, R. (1994) · PubMed · Cited by 603
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Kurtova, A. V., Xiao, J., Mo, Q., Pazhanisamy, S., Krasnow, R., Lerner, S. P., Chen, F., Roh, T. T., Lay, E., Ho, P. L., et al. (2015) · Nature · doi:10.1038/nature14034 · Cited by 578
Sanchez-Carbayo, M., Socci, N. D., Lozano, J., Saint, F., & Cordon-Cardo, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2375 · Cited by 550
Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., & Qiu, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.033 · Cited by 549
Identifying distinct classes of bladder carcinoma using microarrays
Dyrskjøt, L., Thykjaer, T., Kruhøffer, M., Jensen, J. L., Marcussen, N., Hamilton-Dutoit, S., Wolf, H., & Ørntoft, T. F. (2003) · Nature Genetics · doi:10.1038/ng1061 · Cited by 501
Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors
Billerey, C., Chopin, D., Aubriot-Lorton, M.-H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M.-P., Lefrere-Belda, M.-A., Lahaye, J.-B., Abbou, C. C., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64665-2 · Cited by 498
Guo, G., Sun, X., Chen, C., Wu, S., Huang, P., Li, Z., Dean, M., Huang, Y., Jia, W., Zhou, Q., et al. (2013) · Nature Genetics · doi:10.1038/ng.2798 · Cited by 482
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2044 · Cited by 455
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
Hovestadt, V., Jones, D. T. W., Picelli, S., Wang, W., Kool, M., Northcott, P. A., Sultan, M., Stachurski, K., Ryzhova, M., Warnatz, H.-J., et al. (2014) · Nature · doi:10.1038/nature13268 · Cited by 450
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
Shin, K., Lee, J., Guo, N., Kim, J., Lim, A., Qu, L., Mysorekar, I. U., & Beachy, P. A. (2011) · Nature · doi:10.1038/nature09851 · Cited by 443
Zhao, L., & Vogt, P. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712169105 · Cited by 437
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
Solomon, D. A., Kim, T., Diaz-Martinez, L. A., Fair, J., Elkahloun, A. G., Harris, B. T., Toretsky, J. A., Rosenberg, S. A., Shukla, N., Ladanyi, M., et al. (2011) · Science · doi:10.1126/science.1203619 · Cited by 436
Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss
Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., & Sidransky, D. (1994) · Science · doi:10.1126/science.8023167 · Cited by 427
Adam, L., Zhong, M., Choi, W., Qi, W., Nicoloso, M., Arora, A., Calin, G., Wang, H., Siefker-Radtke, A., McConkey, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2245 · Cited by 412
TGF-β–Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12
Fan, Y., Shen, B., Tan, M., Mu, X., Qin, Y., Zhang, F., & Liu, Y. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1455 · Cited by 410
Kim, W.-J., Kim, E.-J., Kim, S.-K., Kim, Y.-J., Ha, Y.-S., Jeong, P., Kim, M.-J., Yun, S.-J., Lee, K., Moon, S.-K., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-3 · Cited by 398
Oncogenic FGFR3 gene fusions in bladder cancer
Williams, S. V., Hurst, C. D., & Knowles, M. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds486 · Cited by 390
Self-citationRebouissou, S., Bernard-Pierrot, I., de Reyniès, A., Lepage, M.-L., Krucker, C., Chapeaublanc, E., Hérault, A., Kamoun, A., Caillault, A., Letouzé, E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008970 · Cited by 386
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25461 · Cited by 367
Tomlinson, D., Baldo, O., Harnden, P., & Knowles, M. (2007) · The Journal of Pathology · doi:10.1002/path.2207 · Cited by 363
Self-citationFGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
Jebar, A. H., Hurst, C. D., Tomlinson, D. C., Johnston, C., Taylor, C. F., & Knowles, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208705 · Cited by 340
Self-citationBladder Cancer Outcome and Subtype Classification by Gene Expression
Blaveri, E., Simko, J. P., Korkola, J. E., Brewer, J. L., Baehner, F., Mehta, K., DeVries, S., Koppie, T., Pejavar, S., Carroll, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2409 · Cited by 337
Hernández, S., López-Knowles, E., Lloreta, J., Kogevinas, M., Amorós, A., Tardón, A., Carrato, A., Serra, C., Malats, N., & Real, F. X. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1771 · Cited by 334
The Uroepithelium: Not Just a Passive Barrier
Apodaca, G. (2004) · Traffic · doi:10.1046/j.1600-0854.2003.00156.x · Cited by 332
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Catto, J. W. F., Miah, S., Owen, H. C., Bryant, H., Myers, K., Dudziec, E., Larré, S., Milo, M., Rehman, I., Rosario, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0744 · Cited by 329
Self-citationInactivation of p53 and Pten promotes invasive bladder cancer
Puzio-Kuter, A. M., Castillo-Martin, M., Kinkade, C. W., Wang, X., Shen, T. H., Matos, T., Shen, M. M., Cordon-Cardo, C., & Abate-Shen, C. (2009) · Genes & Development · doi:10.1101/gad.1772909 · Cited by 329
p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer
Shariat, S. F., Tokunaga, H., Zhou, J., Kim, J., Ayala, G. E., Benedict, W. F., & Lerner, S. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.118 · Cited by 327
Kompier, L. C., Lurkin, I., van der Aa, M. N. M., van Rhijn, B. W. G., van der Kwast, T. H., & Zwarthoff, E. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013821 · Cited by 315
Lindgren, D., Frigyesi, A., Gudjonsson, S., Sjödahl, G., Hallden, C., Chebil, G., Veerla, S., Ryden, T., Månsson, W., Liedberg, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4213 · Cited by 310
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Choi, W., Czerniak, B., Ochoa, A., Su, X., Siefker-Radtke, A., Dinney, C., & McConkey, D. J. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.129 · Cited by 302
Allory, Y., Beukers, W., Sagrera, A., Flández, M., Marqués, M., Márquez, M., van der Keur, K. A., Dyrskjot, L., Lurkin, I., Vermeij, M., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.052 · Cited by 284
p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
Carnero, A., Hudson, J. D., Price, C. M., & Beach, D. H. (2000) · Nature Cell Biology · doi:10.1038/35004020 · Cited by 279
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
Balbás-Martínez, C., Sagrera, A., Carrillo-de-Santa-Pau, E., Earl, J., Márquez, M., Vazquez, M., Lapi, E., Castro-Giner, F., Beltran, S., Bayés, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2799 · Cited by 273
Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
Lamouille, S., Subramanyam, D., Blelloch, R., & Derynck, R. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.008 · Cited by 259
Three differentiation states risk-stratify bladder cancer into distinct subtypes
Volkmer, J.-P., Sahoo, D., Chin, R. K., Ho, P. L., Tang, C., Kurtova, A. V., Willingham, S. B., Pazhanisamy, S. K., Contreras-Trujillo, H., Storm, T. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120605109 · Cited by 259
Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
Platt, F. M., Hurst, C. D., Taylor, C. F., Gregory, W. M., Harnden, P., & Knowles, M. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0898 · Cited by 251
Self-citationMolecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Knowles, M. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi310 · Cited by 248
Self-citationLindgren, D., Sjödahl, G., Lauss, M., Staaf, J., Chebil, G., Lövgren, K., Gudjonsson, S., Liedberg, F., Patschan, O., Månsson, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038863 · Cited by 219
López-Knowles, E., Hernández, S., Malats, N., Kogevinas, M., Lloreta, J., Carrato, A., Tardón, A., Serra, C., Real, F. X., & EPICURO Study Group Investigators (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1182 · Cited by 218
Hartmann, A., Schlake, G., Zaak, D., Hungerhuber, E., Hofstetter, A. G., Hofstaedter, F., & Knuechel, R. (2002) · PubMed · Cited by 216
Frequent truncating mutations of STAG2 in bladder cancer
Solomon, D. A., Kim, J.-S., Bondaruk, J., Shariat, S. F., Wang, Z.-F., Elkahloun, A. G., Ozawa, T., Gerard, J., Zhuang, D., Zhang, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2800 · Cited by 208
Reinert, T., Modin, C., Castano, F. M., Lamy, P., Wojdacz, T. K., Hansen, L. L., Wiuf, C., Borre, M., Dyrskjøt, L., & Ørntoft, T. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2659 · Cited by 207
Dyrskjøt, L., Zieger, K., Real, F. X., Malats, N., Carrato, A., Hurst, C., Kotwal, S., Knowles, M., Malmström, P.-U., de la Torre, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2940 · Cited by 206
Self-citationCellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma
Shin, K., Lim, A., Odegaard, J. I., Honeycutt, J. D., Kawano, S., Hsieh, M. H., & Beachy, P. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2956 · Cited by 199
Bladder cancers arise from distinct urothelial sub-populations
Van Batavia, J., Yamany, T., Molotkov, A., Dan, H., Mansukhani, M., Batourina, E., Schneider, K., Oyon, D., Dunlop, M., Wu, X.-R., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3038 · Cited by 199
Shin, K., Lim, A., Zhao, C., Sahoo, D., Pan, Y., Spiekerkoetter, E., Liao, J. C., & Beachy, P. A. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.001 · Cited by 199
Baumgart, E., Cohen, M. S., Neto, B. S., Jacobs, M. A., Wotkowicz, C., Rieger-Christ, K. M., Biolo, A., Zeheb, R., Loda, M., Libertino, J. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2330 · Cited by 192
Hartmann, A., Moser, K., Kriegmair, M., Hofstetter, A., Hofstaedter, F., & Knuechel, R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65318-7 · Cited by 189
Urakami, S., Shiina, H., Enokida, H., Kawakami, T., Tokizane, T., Ogishima, T., Tanaka, Y., Li, L.-C., Ribeiro-Filho, L. A., Terashima, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1344 · Cited by 189
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
Kiemeney, L. A., Sulem, P., Besenbacher, S., Vermeulen, S. H., Sigurdsson, A., Thorleifsson, G., Gudbjartsson, D. F., Stacey, S. N., Gudmundsson, J., Zanon, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.558 · Cited by 188
Self-citationA new tumor suppressor role for the Notch pathway in bladder cancer
Rampias, T., Vgenopoulou, P., Avgeris, M., Polyzos, A., Stravodimos, K., Valavanis, C., Scorilas, A., & Klinakis, A. (2014) · Nature Medicine · doi:10.1038/nm.3678 · Cited by 184
Normal and neoplastic urothelial stem cells: getting to the root of the problem
Ho, P. L., Kurtova, A., & Chan, K. S. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.142 · Cited by 184
Toward a Molecular Pathologic Classification of Urothelial Carcinoma
Sjödahl, G., Lövgren, K., Lauss, M., Patschan, O., Gudjonsson, S., Chebil, G., Aine, M., Eriksson, P., Månsson, W., Lindgren, D., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.05.013 · Cited by 180
Wolff, E. M., Chihara, Y., Pan, F., Weisenberger, D. J., Siegmund, K. D., Sugano, K., Kawashima, K., Laird, P. W., Jones, P. A., & Liang, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1335 · Cited by 180
p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
Williamson, M. P., Elder, P. A., Shaw, M. E., Devlin, J., & Knowles, M. A. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.9.1569 · Cited by 179
Self-citationHER2 overexpression in muscle‐invasive urothelial carcinoma of the bladder: Prognostic implications
Krüger, S., Weitsch, G., Büttner, H., Matthiensen, A., Böhmer, T., Marquardt, T., Sayk, F., Feller, A. C., & Böhle, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10731 · Cited by 176
Takahashi, T., Habuchi, T., Kakehi, Y., Mitsumori, K., Akao, T., Terachi, T., & Yoshida, O. (1998) · PubMed · Cited by 176
Lopez-Knowles, E., Hernandez, S., Malats, N., Kogevinas, M., Lloreta, J., Carrato, A., Tardon, A., Serra, C., & Real, F. X. (2006) · European Urology Supplements · doi:10.1016/s1569-9056(06)61338-9 · Cited by 173
Renard, I., Joniau, S., van Cleynenbreugel, B., Collette, C., Naômé, C., Vlassenbroeck, I., Nicolas, H., de Leval, J., Straub, J., Van Criekinge, W., et al. (2010) · European Urology · doi:10.1016/j.eururo.2009.07.041 · Cited by 167
Profiling Bladder Cancer Using Targeted Antibody Arrays
Sanchez-Carbayo, M., Socci, N. D., Lozano, J. J., Haab, B. B., & Cordon-Cardo, C. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050601 · Cited by 167
Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma
van der Horst, G., Bos, L., & van der Pluijm, G. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0274 · Cited by 162
Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments
Chung, W., Bondaruk, J., Jelinek, J., Lotan, Y., Liang, S., Czerniak, B., & Issa, J.-P. J. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0067 · Cited by 159
Hurst, C. D., Platt, F. M., & Knowles, M. A. (2013) · European Urology · doi:10.1016/j.eururo.2013.08.057 · Cited by 157
Self-citationTran, M., Choi, W., Wszolek, M. F., Navai, N., Lee, I.-L. C., Nitti, G., Wen, S., Flores, E. R., Siefker-Radtke, A. O., Czerniak, B. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408104 · Cited by 156
Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
Nordentoft, I., Lamy, P., Birkenkamp‐Demtröder, K., Shumansky, K., Vang, S., Hornshøj, H., Juul, M., Villesen, P., Hedegaard, J., Roth, A. J. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.038 · Cited by 151
Karni-Schmidt, O., Castillo-Martín, M., HuaiShen, T., Gladoun, N., Domenech, J. M. D., Sänchez‐Carbayo, M., Li, Y., Lowe, S. W., Prives, C. L., & Cordon‐Cardo, C. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.061 · Cited by 145
Yuan, X., Yu, L., Li, J., Xie, G., Rong, T., Zhang, L. N., Chen, J., Meng, Q., Irving, A. T., Wang, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3879 · Cited by 142
Somatic mutation of PTEN in bladder carcinoma
Aveyard, J. S., Skilleter, A., Habuchi, T., & Knowles, M. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690439 · Cited by 138
Self-citationTomlinson, D. C., Lamont, F. R., Shnyder, S. D., & Knowles, M. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2816 · Cited by 138
Self-citationSaid, N. A., Sänchez‐Carbayo, M., Smith, S. C., & Theodorescu, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61392 · Cited by 135
Marsit, C. J., Karagas, M. R., Andrew, A. S., Liu, M., Danaee, H., Schned, A. R., Nelson, H. H., & Kelsey, K. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0267 · Cited by 134
Amplification at chromosome 11q13 in transitional cell tumours of the bladder.
Proctor, A. J., Coombs, L., Cairns, J. P., & Knowles, M. A. (1991) · PubMed · Cited by 134
Self-citationDifferentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma
He, X., Marchionni, L., Hansel, D. E., Yu, W., Sood, A., Yang, J., Parmigiani, G., Matsui, W. H., & Berman, D. M. (2009) · Stem Cells · doi:10.1002/stem.92 · Cited by 127
Benedict, W. F., Lerner, S. P., Zhou, J., Shen, X., Tokunaga, H., & Czerniak, B. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202452 · Cited by 126
Habuchi, T., Luscombe, M., Elder, P. A., & Knowles, M. A. (1998) · Genomics · doi:10.1006/geno.1997.5165 · Cited by 126
Self-citationRebouissou, S., Hérault, A., Letouzé, É., Neuzillet, Y., Laplanche, A., Ofualuka, K., Maillé, P., Leroy, K., Riou, A., Lepage, M., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4017 · Cited by 122
Bentley, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh842 · Cited by 120
Sjödahl, G., Lauss, M., Guðjónsson, S., Liedberg, F., Halldén, C., Chebil, G., Månsson, W., Höglund, M., & Lindgren, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018583 · Cited by 119
Overdevest, J. B., Thomas, S., Kristiansen, G., Hansel, D. E., Smith, S. C., & Theodorescu, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0519 · Cited by 119
Partial allelotype of carcinoma in situ of the human bladder.
Rosin, M. P., Cairns, P., Epstein, J. I., Schoenberg, M., & Sidransky, D. (1995) · PubMed · Cited by 118
Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Hurst, C. D., Platt, F. M., Taylor, C., & Knowles, M. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1807 · Cited by 112
Self-citationKandimalla, R., van Tilborg, A. A. G., Kompier, L. C., Stumpel, D. J. P. M., Stam, R. W., Bangma, C. H., & Zwarthoff, E. C. (2012) · European Urology · doi:10.1016/j.eururo.2012.01.011 · Cited by 110
The INK4a/ARF locus in murine tumorigenesis
Serrano, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.865 · Cited by 109
di Martino, E., L’Hôte, C., Kennedy, W., Tomlinson, D. C., & Knowles, M. A. (2009) · Oncogene · doi:10.1038/onc.2009.280 · Cited by 108
Self-citationHurst, C. D., Tomlinson, D. C., Williams, S. V., Platt, F. M., & Knowles, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210934 · Cited by 108
Self-citationMorris, Q., Liu, P., Woloszynska‐Read, A., Zhang, J., Luo, W. F., Qin, M., Bshara, W., Conroy, J. M., Sabatini, L. M., Vedell, P. T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313580111 · Cited by 108
Distinct Functions of Human Cohesin-SA1 and Cohesin-SA2 in Double-Strand Break Repair
Kong, X., Ball, A. R., Pham, H. X., Zeng, W., Chen, H.-Y., Schmiesing, J. A., Kim, J.-S., Berns, M. W., & Yokomori, K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01503-13 · Cited by 102
Loss of SPARC in bladder cancer enhances carcinogenesis and progression
Said, N. A., Frierson, H. F., Sänchez‐Carbayo, M., Brekken, R. A., & Theodorescu, D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64782 · Cited by 101
Letouzé, É., Allory, Y., Bollet, M. A., Radvanyi, F., & Guyon, F. (2010) · Genome biology · doi:10.1186/gb-2010-11-7-r76 · Cited by 101
The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer
van Rhijn, B. W. G., van der Kwast, T., Liu, L., Fleshner, N. E., Boström, P. J., Vis, A. N., Alkhateeb, S. S., Bangma, C. H., Jewett, M. A. S., Zwarthoff, E. C., et al. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.09.008 · Cited by 101
β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation
Ahmad, I., Morton, J. P., Singh, L. B., Radulescu, S., Ridgway, R. A., Patel, S., Woodgett, J. R., Winton, D. J., Taketo, M. M., Wu, X., et al. (2010) · Oncogene · doi:10.1038/onc.2010.399 · Cited by 99
Cheng, H., Trink, B., Tzai, T.-S., Liu, H.-S., Chan, S.-H., Ho, C.-L., Sidransky, D., & Chow, N.-H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1544 · Cited by 97
FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms
Tomlinson, D. C., Baxter, E. W., Loadman, P. M., Hull, M. A., & Knowles, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038972 · Cited by 96
Self-citationKassouf, W., Black, P. C., Tuziak, T., Bondaruk, J. E., Lee, S., Brown, G. A., Adam, L., Wei, C., Baggerly, K., Bar‐Eli, M., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.08.087 · Cited by 95
Overdevest, J. B., Knubel, K. H., Duex, J. E., Thomas, S., Nitz, M. D., Harding, M. A., Smith, S. C., Frierson, H. F., Conaway, M. R., & Theodorescu, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113960109 · Cited by 95
Zieger, K., Dyrskjøt, L., Wiuf, C., Jensen, J. L., Andersen, C. L., Jensen, K. M., & Orntoft, T. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1130 · Cited by 93
PTCH gene mutations in invasive transitional cell carcinoma of the bladder
Tw, M., Maruta, Y., Tomaszewski, J. E., Aj, L., & Malkowicz, S. B. (1998) · Oncogene · doi:10.1038/sj.onc.1202045 · Cited by 92
Identification of Methylated Genes Associated with Aggressive Bladder Cancer
Marsit, C. J., Houseman, E. A., Christensen, B. C., Gagne, L. A., Wrensch, M., Nelson, H. H., Wiemels, J. L., Zheng, S., Wiencke, J. K., Andrew, A. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012334 · Cited by 92
Molecular evolution of multiple recurrent cancers of the bladder
van Tilborg, A. A. G. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.2973 · Cited by 91
Liang Cheng, C., Gu, J., Ulbright, T. M., MacLennan, G. T., Sweeney, C. J., Zhang, S., Sanchez, K., Koch, M. O., & Eble, J. N. (2001) · Cancer · doi:10.1002/cncr.10151 · Cited by 84
p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
Choi, W., Shah, J. B., Tran, M., Svatek, R. S., Marquis, L., Lee, I.-L., Yu, D., Adam, L., Wen, S., Shen, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030206 · Cited by 84
Vallot, C., Stransky, N., Bernard‐Pierrot, I., Hérault, A., Zucman‐Rossi, J., Chapeaublanc, E., Vordos, D., Laplanche, A., Benhamou, S., Lebrét, T., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq470 · Cited by 82
Majewski, T., Lee, S., Jeong, J., Yoon, D. S., Kram, A., Kim, M., Tuziak, T., Bondaruk, J. E., Lee, S., Park, W. S., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.27 · Cited by 81
Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function
Wu, Y., Moissoglu, K., Wang, H., Wang, X., Frierson, H. F., Schwartz, M. A., & Theodorescu, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810094106 · Cited by 80
Cheng, T., Roth, B., Choi, W., Black, P. C., Dinney, C. P., & McConkey, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057284 · Cited by 77
Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis
Ahmad, I., Patel, R., Liu, Y., Singh, L. B., Taketo, M. M., Wu, X., Leung, H. Y., & Sansom, O. J. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.7 · Cited by 74
Tomlinson, D. C., L’Hôte, C., Kennedy, W., Pitt, E., & Knowles, M. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1718 · Cited by 74
Self-citationActivities of MAP-Kinase Pathways in Normal Uroepithelial Cells and Urothelial Carcinoma Cell Lines
Swiatkowski, S. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5647 · Cited by 71
Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma
Nord, H., Segersten, U., Sandgren, J., Wester, K., Busch, C., Menzel, U., Komorowski, J., Dumanski, J. P., Malmström, P., & de Ståhl, T. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24954 · Cited by 70
Prognostic Value of Cell-Cycle Regulation Biomarkers in Bladder Cancer
Mitra, A. P., Hansel, D. E., & Côté, R. J. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.08.008 · Cited by 70
Tomlinson, D. C., & Knowles, M. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100354 · Cited by 70
Self-citationHopman, A. H. N., Kamps, M. A. F., Speel, E. M., Schapers, R. F. M., Sauter, G., & Ramaekers, F. C. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64388-x · Cited by 69
The human urothelium consists of multiple clonal units, each maintained by a stem cell
Gaisa, N. T., Graham, T. A., McDonald, S. A. C., Cañadillas, S., Poulsom, R., Heidenreich, A., Jakse, G., Tadrous, P. J., Knuechel, R., & Wright, N. A. (2011) · The Journal of Pathology · doi:10.1002/path.2945 · Cited by 68
Juanpere-Rodero, N., Agell, L., Lorenzo, M., de Muga, S., López-Vilaró, L., Murillo, R., Mojal, S., Serrano, S., Lorente, J. A., Lloreta, J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.10.026 · Cited by 66
Alteration of the PATCHED locus in superficial bladder cancer
Aboulkassim, T., LaRue, H., Lemieux, P., Rousseau, F., & Fradet, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206513 · Cited by 65
Loss of SPARC in bladder cancer enhances carcinogenesis and progression
Said, N. A., Frierson, H. F., Sänchez‐Carbayo, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71241 · Cited by 63
Saito, R., Shirakawa, R., Nishiyama, H., Kobayashi, T., Kawato, M., Kanno, T., Nishizawa, K., Matsui, Y., Ohbayashi, T., Horiguchi, M., et al. (2012) · Oncogene · doi:10.1038/onc.2012.101 · Cited by 62
Constitutive β-Catenin Activation Induces Male-Specific Tumorigenesis in the Bladder Urothelium
Lin, C., Yin, Y., Stemler, K. M., Humphrey, P. A., Kibel, A. S., Mysorekar, I. U., & Ma, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4198 · Cited by 60
Hypermethylation in bladder cancer: biological pathways and translational applications
Sänchez‐Carbayo, M. (2012) · Tumor Biology · doi:10.1007/s13277-011-0310-2 · Cited by 59
New Insights into Subtypes of Invasive Bladder Cancer: Considerations of the Clinician
McConkey, D. J., Choi, W., & Dinney, C. P. (2014) · European Urology · doi:10.1016/j.eururo.2014.05.006 · Cited by 58
Elevated expression of pp60c-src in low grade human bladder carcinoma.
Fanning, P., Bulovas, K., Saini, K. S., Libertino, J. A., Joyce, A. D., & Summerhayes, I. C. (1992) · PubMed · Cited by 54
Epigenetics of Kidney Cancer And Bladder Cancer
Hoffman, A. M., & Cairns, P. (2011) · Epigenomics · doi:10.2217/epi.10.64 · Cited by 54
Lauss, M., Aine, M., Sjödahl, G., Veerla, S., Patschan, O., Guðjónsson, S., Chebil, G., Lövgren, K., Fernö, M., Månsson, W., et al. (2012) · Epigenetics · doi:10.4161/epi.20837 · Cited by 53
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia
Lee, S., Jeong, J., Majewski, T., Scherer, S. E., Kim, M.-S., Tuziak, T., Tang, K. S., Baggerly, K., Grossman, H. B., Zhou, J.-H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701771104 · Cited by 52
Zieger, K., Marcussen, N., Borre, M., Orntoft, T. F., & Dyrskjøt, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24619 · Cited by 51
Global Epigenetic Profiling In Bladder Cancer
Dudziec, E., Goepel, J. R., & Catto, J. W. F. (2011) · Epigenomics · doi:10.2217/epi.10.71 · Cited by 44
Ross, R. L., Askham, J. M., & Knowles, M. A. (2012) · Oncogene · doi:10.1038/onc.2012.87 · Cited by 43
Self-citationBladder cancer subtypes defined by genomic alterations
Knowles, M. A. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/03008880802284605 · Cited by 41
Self-citationDudziec, E., Gogol‐Döring, A., Cookson, V. J., Chen, W., & Catto, J. W. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032750 · Cited by 37
Said, N. A., & Theodorescu, D. (2012) · OncoImmunology · doi:10.4161/onci.20594 · Cited by 37
Urinary Bladder Cancer Susceptibility Markers. What Do We Know about Functional Mechanisms?
Dudek, A. M., Grotenhuis, A. J., Vermeulen, S. H. H. M., Kiemeney, L. A. L. M., & Verhaegh, G. W. C. T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612346 · Cited by 35
Epigenetic biomarkers in urothelial bladder cancer
Kim, W., & Kim, Y. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.5 · Cited by 34
Wilhelm-Benartzi, C. S., Koestler, D. C., Houseman, E. A., Christensen, B. C., Wiencke, J. K., Schned, A. R., Karagas, M. R., Kelsey, K. T., & Marsit, C. J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq178 · Cited by 34
The faces and friends of RhoGDI2
Griner, E., & Theodorescu, D. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9376-6 · Cited by 33
de Medina, S. G. D., Popov, Z., Chopin, D. K., Southgate, J., Tucker, G. C., Delouvée, A., Thiery, J. P., & Radvanyi, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202958 · Cited by 33
Frère‐Belda, M. L. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.01.019 · Cited by 29
Κάρλου, Μ., Saetta, A. A., Korkolopoulou, P. A., Levidou, G., Papanastasiou, P., Boltetsou, E., Isaiadis, D., Pavlopoulos, P. M., Thymara, I., Thomas-Tsagli, E., et al. (2009) · Pathology · doi:10.1080/00313020902885011 · Cited by 28
Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines
Thievessen, I., Wolter, M., Prior, A., Seifert, H., & Schulz, W. A. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20248 · Cited by 27
CTCF and cohesin cooperate to organize the 3D structure of the mammalian genome
Baranello, L., Kouzine, F., & Levens, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321957111 · Cited by 25
Expression of NRG1 and its receptors in human bladder cancer
Forster, J. A., Paul, A., Harnden, P., & Knowles, M. A. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.39 · Cited by 24
Self-citationThe Ral GTPase pathway in metastatic bladder cancer: Key mediator and therapeutic target
Smith, S. C., & Theodorescu, D. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.04.012 · Cited by 23
The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder
Qayyum, T., Fyffe, G., Duncan, M., McArdle, P., Hilmy, M., Orange, C., Halbert, G., Seywright, M. M., Horgan, P. G., Underwood, M. A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.52 · Cited by 21
Eriksson, P., Aine, M., Sjödahl, G., Staaf, J., Lindgren, D., & Höglund, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067222 · Cited by 12
McConkey, D. J., Choi, W., & Dinney, C. P. (2014) · European Urology · doi:10.1016/j.eururo.2014.08.064 · Cited by 5
Cited by
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Lee, S. H., Hu, W., Matulay, J. T., Silva, M. V., Owczarek, T. B., Kim, K., Chua, C. W., Barlow, L. J., Kandoth, C., Williams, A. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.017 · Cited by 873
Exosome detection via the ultrafast-isolation system: EXODUS
Chen, Y., Zhu, Q., Cheng, L., Wang, Y., Li, M., Yang, Q., Hu, L., Lou, D., Li, J., Dong, X., et al. (2021) · Nature Methods · doi:10.1038/s41592-020-01034-x · Cited by 412
Pietzak, E. J., Bagrodia, A., Cha, E. K., Drill, E. N., Iyer, G., Isharwal, S., Ostrovnaya, I., Baez, P., Li, Q., Berger, M. F., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.05.032 · Cited by 373
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Dudley, J. C., Schroers-Martin, J., Lazzareschi, D. V., Shi, W. Y., Chen, S. B., Esfahani, M. S., Trivedi, D., Chabon, J. J., Chaudhuri, A. A., Stehr, H., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0825 · Cited by 253
MOGSA: Integrative Single Sample Gene-set Analysis of Multiple Omics Data
(2019) · doi:10.1074/mcp.tir118.001251 · Cited by 78
Metadata
- Authors
- Knowles, M. A., & Hurst, C. D.
- Venue
- Nature Reviews Cancer
- Published
- 2014-12-23
- Volume
- 15
- Issue
- 1
- Pages
- 25-41
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2035297454
- Cited by
- 1,247
- References
- 161
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.